Abstract
Climate factors are known to influence seasonal patterns of dengue transmission. However, little is known about the effect of extremes of temperature on the severity of dengue infection, such as hospital admission. We aimed to quantify the effect of ambient temperature on dengue hospitalisation risk in Brazil. We retrieved daily dengue hospitalisation counts by each of 5,565 municipalities across the 27 states of Brazil from 1st of January 2010 to 31st of December 2019, from the Brazilian Public Hospital Admission System (“SIH”). We obtained average daily ambient temperature for each municipality from the ERA5-land product reanalysis. We combined distributed lag non-linear models with time stratified design model framework to pool a relative risk (RR) estimate for dose-response and lag-response structures for the association of temperature and Dengue hospitalisation. We estimate the overall dengue hospitalisation RR for the whole country as well for each of the five macro-regions by meta-analysing state level estimates. 579,703 hospital admissions due to dengue occurred over the 10 years’ period of 2010 to 2019. We observed a positive association between high temperatures and high risk of hospitalisation for Brazil. The overall RR for dengue hospitalisation was 2.185 (95% CI 1.457- 3.276) at the 50th percentile of temperature and 2.385 (95% CI 1.556-3.655) at 95th percentile of temperature for Brazil. We also found lag effects of heat on hospitalisation, particularly an immediate augmented risk to hospitalisation, both at the 50th percentile and 95th. High temperatures are associated with an increase in the risk of hospitalisation by dengue. These findings may guide preparedness and mitigation policies during dengue season outbreaks, particularly on the health-care demand.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Conselho Nacional de Pesquisa, Coordenacao Nacional de Aperfeicoamento de Pessoal, Institut de Salud Carlos III.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All the data were got from the Brazillian Hospital Admission System (SIH), that can be accessed thourgh the link: - http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sih/cnv/qibr.def
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The version of the manuscript has been revised in its structure. New figures were added as well as new numbering of all figures and tables. The manuscript now has page numbers and line numbering.
Data Availability Statement
All data used in this study are publicly available. Hospitalisation data is available at http://sihd.datasus.gov.br/principal/index.php, and temperature at https://cds.climate.copernicus.eu/#!/home. The code to reproduce this analysis is available at: https://github.com/rafalopespx/dengue_t2m_severity_paper
